INMUNOGENICIDAD DE UNA PROTEÍNA MULTI-EPITÓPICA COMO CANDIDATA PARA VACUNA CONTRA LA ENFERMEDAD DE CARRIÓN.

Autor: Rojas, Carlos Padilla¹, Pari, Priscila Lope¹, Mogollon, Cleidy Osorio¹, Angulo, Lisbet Inga¹, Solis, Lorena Santos¹, Calderon, Henri Bailon¹, Ñique, Adolfo Marcelo¹, Tarazona, Jackeline Morales², Egusquiza, Gladis Ventura¹

Publikováno v: Revista Peruana de Medicina Experimental y Salud Pública. 2017 Supplement, Vol. 34, p38-39. 2p.

PRODUCCIÓN DE NANOANTICUERPOS RECOMBINANTES CONTRA PROTEÍNAS DEL VENENO DE BOTHROPS ATROX.

Autor: Calderon, Henri Bailon¹, Colque, E.¹, Leiva, W.¹, Cáceres, O.¹, Padilla, C.¹, Montejo, H.¹, Yaniro, V.¹, García, D.¹, Tintaya, B.², Lévano, J.¹, Celis, M.¹, Romao, E.³, Smiejkowska, N.³, Muyldermans, S.³, Calero, A.⁴, Galarza, M.¹, Bonilla, C.², Seraylan, S.¹, Inga, R.², Ventura, G.¹

Publikováno v: Revista Peruana de Medicina Experimental y Salud Pública. 2017 Supplement, Vol. 34, p39-39. 1/2p.

Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.

Autor: Bastos ML, Hussain H, Weyer K, Garcia-Garcia L, Leimane V, Leung CC, Narita M, Penã JM, Ponce-de-Leon A, Seung KJ, Shean K, Sifuentes-Osornio J, Van der Walt M, Van der Werf TS, Yew WW, Menzies D

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2014 Nov 15; Vol. 59 (10), pp. 1364-74. Date of Electronic Publication: 2014 Aug 05.

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.

Autor: Migliori GB; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy., Sotgiu G; Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Sassari, Italy., Gandhi NR; Department of Medicine and Department of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA., Falzon D; STOP TB Department, World Health Organization, Geneva, Switzerland., DeRiemer K; School of Medicine, University of California Davis, Davis, California, USA., Centis R; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy., Hollm-Delgado MG; Montreal Chest Institute, McGill University, Montreal, Canada., Palmero D; Pulmonology Division, Hospital F. J. Muñiz, Buenos Aires, Argentina., Pérez-Guzmán C; Instituto de Servicios de Salud del Estado de Aguascalientes, and Unidad de Medicina Ambulatoria Aguascalientes, Instituto Mexicano del Seguro Social, Aguascalientes, Mexico., Vargas MH; Instituto Nacional de Enfermedades Respiratorias, and Medical Research Unit in Respiratory Diseases, Instituto Mexicano del Seguro Social, Mexico DF, Mexico., D'Ambrosio L; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy., Spanevello A; Università degli Studi dell'Insubria, Varese, and Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy., Bauer M; Montreal Chest Institute, McGill University, Montreal, Canada., Chan ED; Pulmonary Department, Denver Veterans Affair Medical Center and National Jewish Health, Denver, Colorado, USA., Schaaf HS; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa., Keshavjee S; Department of Global Health & Social Medicine Harvard Medical School, Boston, Massachusetts, USA., Holtz TH; Centers for Disease Control and Prevention, Atlanta, GA, USA., Menzies D; Montreal Chest Institute, McGill University, Montreal, Canada.

Publikováno v: The European respiratory journal [Eur Respir J] 2013 Jul; Vol. 42 (1), pp. 169-179. Date of Electronic Publication: 2012 Oct 11.